INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis
USA - NASDAQ:ISRG - US46120E6023 - Common Stock
543.28 USD
-3.23 (-0.59%)
Overall ISRG gets a fundamental rating of 7 out of 10. We evaluated ISRG against 189 industry peers in the Health Care Equipment & Supplies industry. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ISRG is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
ISRG had a positive operating cash flow in the past year.
Each year in the past 5 years ISRG has been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.93%, ISRG belongs to the top of the industry, outperforming 94.71% of the companies in the same industry.
The Return On Equity of ISRG (14.61%) is better than 90.48% of its industry peers.
With an excellent Return On Invested Capital value of 12.92%, ISRG belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 9.00%.
The 3 year average ROIC (12.20%) for ISRG is below the current ROIC(12.92%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROIC | 12.92% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
ISRG's Profit Margin of 28.51% is amongst the best of the industry. ISRG outperforms 95.77% of its industry peers.
ISRG's Profit Margin has declined in the last couple of years.
ISRG has a Operating Margin of 28.96%. This is amongst the best in the industry. ISRG outperforms 96.83% of its industry peers.
ISRG's Operating Margin has declined in the last couple of years.
The Gross Margin of ISRG (66.61%) is better than 71.43% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ISRG is still creating some value.
The number of shares outstanding for ISRG has been increased compared to 1 year ago.
The number of shares outstanding for ISRG has been increased compared to 5 years ago.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 52.56 indicates that ISRG is not in any danger for bankruptcy at the moment.
ISRG's Altman-Z score of 52.56 is amongst the best of the industry. ISRG outperforms 99.47% of its industry peers.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 52.56 |
ROIC/WACC1.49
WACC8.66%
2.3 Liquidity
A Current Ratio of 5.17 indicates that ISRG has no problem at all paying its short term obligations.
The Current ratio of ISRG (5.17) is better than 79.37% of its industry peers.
A Quick Ratio of 4.18 indicates that ISRG has no problem at all paying its short term obligations.
ISRG has a Quick ratio of 4.18. This is in the better half of the industry: ISRG outperforms 78.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
The Earnings Per Share has been growing by 11.48% on average over the past years. This is quite good.
The Revenue has grown by 22.18% in the past year. This is a very strong growth!
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
Based on estimates for the next years, ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.53% on average per year.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.89% yearly.
EPS Next Y13.5%
EPS Next 2Y13.63%
EPS Next 3Y14.59%
EPS Next 5Y14.53%
Revenue Next Year19.68%
Revenue Next 2Y17.01%
Revenue Next 3Y16.2%
Revenue Next 5Y14.89%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 63.10 indicates a quite expensive valuation of ISRG.
67.72% of the companies in the same industry are more expensive than ISRG, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.89. ISRG is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 57.41, which means the current valuation is very expensive for ISRG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.72% of the companies listed in the same industry.
ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.1 | ||
| Fwd PE | 57.41 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than the industry average as 65.08% of the companies are valued more expensively.
ISRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 69.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 97.66 | ||
| EV/EBITDA | 58.46 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ISRG may justify a higher PE ratio.
ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.67
PEG (5Y)5.5
EPS Next 2Y13.63%
EPS Next 3Y14.59%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ISRG (10/27/2025, 11:04:59 AM)
543.28
-3.23 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner Change-0.37%
Ins Owners0.45%
Ins Owner Change0.86%
Market Cap194.76B
Revenue(TTM)9.61B
Net Income(TTM)2.61B
Analysts79
Price Target597.45 (9.97%)
Short Float %2.07%
Short Ratio2.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.33%
Min EPS beat(2)3.05%
Max EPS beat(2)11.61%
EPS beat(4)4
Avg EPS beat(4)11.45%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.83%
EPS beat(12)11
Avg EPS beat(12)6.4%
EPS beat(16)13
Avg EPS beat(16)4.58%
Revenue beat(2)2
Avg Revenue beat(2)1.47%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.84%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)0%
PT rev (3m)-0.26%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)4.02%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.1 | ||
| Fwd PE | 57.41 | ||
| P/S | 21.3 | ||
| P/FCF | 97.66 | ||
| P/OCF | 68.91 | ||
| P/B | 10.91 | ||
| P/tB | 11.14 | ||
| EV/EBITDA | 58.46 |
EPS(TTM)8.61
EY1.58%
EPS(NY)9.46
Fwd EY1.74%
FCF(TTM)5.56
FCFY1.02%
OCF(TTM)7.88
OCFY1.45%
SpS25.51
BVpS49.78
TBVpS48.76
PEG (NY)4.67
PEG (5Y)5.5
Graham Number98.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROCE | 14.34% | ||
| ROIC | 12.92% | ||
| ROICexc | 18.33% | ||
| ROICexgc | 18.86% | ||
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% | ||
| FCFM | 21.81% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 144.66% | ||
| Cap/Sales | 9.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.68% | ||
| Profit Quality | 76.48% | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 52.56 |
F-Score6
WACC8.66%
ROIC/WACC1.49
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y13.5%
EPS Next 2Y13.63%
EPS Next 3Y14.59%
EPS Next 5Y14.53%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year19.68%
Revenue Next 2Y17.01%
Revenue Next 3Y16.2%
Revenue Next 5Y14.89%
EBIT growth 1Y34.8%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.2%
FCF growth 1Y69.15%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y52.09%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 8 / 10.